Connect with others who understand.

Sign up Log in
Resources
About DiabetesTeam
Powered By
See answer

3 Layers of COVID-19 Protection: New Vaccines, Prevention Drug, and Tests

Medically reviewed by Elizabeth Cueto, M.D.
Written by Ted Samson
Posted on October 10, 2024

This fall and winter, the Centers for Disease Control and Prevention (CDC) expects the number of people hospitalized with respiratory viruses like COVID-19, RSV, and influenza to be similar to or lower than last year — but still higher than before the pandemic. To help protect against the latest COVID-19 variants, the U.S. Food and Drug Administration (FDA) has approved updated vaccines.

Separately, the Infectious Diseases Society of America (IDSA) is recommending people who are immunocompromised consider taking pemivibart (Pemgarda), a preventive treatment against severe illness from COVID-19. Recent research also suggests that taking the antiviral treatment nirmatrelvir-ritonavir (Paxlovid) during a COVID-19 infection can lower the risk of long COVID for people with weakened immune systems or underlying health conditions.

Finally, free COVID-19 tests are now available to U.S. households.

Updated COVID-19 Vaccines

The updated messenger RNA (mRNA) COVID-19 vaccines from Moderna and Pfizer are designed specifically to target the most recent variants of the virus, including the omicron KP.2 strain. Similarly, the updated Novavax COVID-19 vaccine — which is protein-based — has been updated to target the omicron JN.1 strain. This targeted approach aims to provide better protection against hospitalization or death from COVID-19.

The CDC recommends everyone ages 6 months and older receive an updated COVID-19 vaccine. “It is especially important to get your 2024-2025 COVID-19 vaccine if you are ages 65 and older, are at high risk for severe COVID-19, or have never received a COVID-19 vaccine,” according to the agency.

Additional Protection for Immunocompromised Individuals

In August, the IDSA released guidelines recommending pemivibart for people 12 and older who are moderately to severely immunocompromised and may not respond effectively to vaccines. Granted an emergency use authorization by the FDA in March 2024, pemivibart is taken to help prevent COVID-19 in people who are not currently infected with SARS-CoV-2 (the virus that causes COVID-19) and have not had recent exposure to someone with the virus. It’s given as an IV infusion and works by neutralizing (stopping or weakening) the virus if the person is exposed to it.

For people who are immunocompromised and do catch COVID-19, taking nirmatrelvir-ritonavir may help reduce their risk of long COVID. The FDA approved the drug in 2023 to treat moderate COVID-19 in people at high risk of severe illness. An observational study found that taking nirmatrelvir-ritonavir was linked to a 12 percent lower chance of developing long COVID — primarily for people with a higher risk of severe illness from COVID-19.

Free Tests Available

Finally, the federal government will offer free COVID-19 tests through the mail. Every U.S. household can order four tests at COVIDTests.gov. These tests will detect current COVID-19 variants.

Should You Consider the New COVID-19 Vaccines or Treatments if You Have Diabetes?

If you have diabetes, you may be at higher risk of complications from COVID-19. This makes it essential to stay up to date on vaccines. Nirmatrelvir-ritonavir may help reduce the severity of COVID-19 if taken early.

However, there’s no one-size-fits-all approach to protecting yourself against COVID-19 if you’re living with diabetes. It’s important to discuss with your doctor whether the latest vaccines or Paxlovid could be suitable for you.

Discover what past research has revealed about COVID-19 vaccines and diabetes.

Find Your Team

If you have questions about COVID-19 vaccines and diabetes, you’re not alone. By joining DiabetesTeam — the social network for people living with diabetes and their loved ones — you can connect with thousands of others who understand life with diabetes.

How have your experiences been with COVID-19 and vaccines? Share your story in the comments, or start a conversation on your Activities page.

Posted on October 10, 2024

A DiabetesTeam Member

Hearing and seeing what the jab will do for you NO THANKS.

October 16
All updates must be accompanied by text or a picture.

We'd love to hear from you! Please share your name and email to post and read comments.

You'll also get the latest articles directly to your inbox.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service.
Privacy Policy
All updates must be accompanied by text or a picture.

Subscribe now to ask your question, get answers, and stay up to date on the latest articles.

Get updates directly to your inbox.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service.
Privacy Policy
Elizabeth Cueto, M.D. graduated from the National Polytechnic Institute in Mexico City. Learn more about her here.
Ted Samson is a copy editor at MyHealthTeam. Learn more about him here.

Recent Articles

If you’re living with type 2 diabetes, you’re well aware of the condition’s impact on your life. ...

Type 2 Diabetes Awareness Month: How To Get Involved

If you’re living with type 2 diabetes, you’re well aware of the condition’s impact on your life. ...
Living with diabetes means you can’t typically reach for snacks like candy bars and potato chips ...

5 Healthy Snack Ideas for Diabetes

Living with diabetes means you can’t typically reach for snacks like candy bars and potato chips ...
Diabetic macular edema (DME) is a relatively common vision problem in people with diabetes. Opti...

How OCT Works To Detect Diabetic Macular Edema: What To Expect

Diabetic macular edema (DME) is a relatively common vision problem in people with diabetes. Opti...
Diabetic macular edema (DME) can be categorized as center-involved or non-center-involved. Cente...

Center-Involved Diabetic Macular Edema vs. Non-Center-Involved: Differences and Management

Diabetic macular edema (DME) can be categorized as center-involved or non-center-involved. Cente...
Some eye damage caused by diabetic retinopathy is irreversible, but early intervention can slow ...

Can Diabetic Retinopathy Be Reversed? Injections, Diet, and More

Some eye damage caused by diabetic retinopathy is irreversible, but early intervention can slow ...
What do diabetes, eye surgeries, and aging have in common? They’re three of the 10 main causes of...

The 10 Causes of Macular Edema: Diabetes and More

What do diabetes, eye surgeries, and aging have in common? They’re three of the 10 main causes of...

Thank you for subscribing!

Become a member to get even more: